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Cell lines are often used in place of primary cells to study biological processes. However, care must be taken when
interpretingtheresultsascelllinesdonotalwaysaccuratelyreplicatetheprimarycells.Inthisarticle,wewillbrieflytalkabout
advantages and disadvantages of cell lines and then discuss results using the mouse Sertoli cell line, MSC-1, compared with
primary mouse Sertoli cells. MSC-1 cells resemble Sertoli cells morphologically and possess several biochemical markers
associated with Sertoli cells. Studies have demonstrated that the function and regulation of retinoic acid receptor a (RARa)i s
similar between MSC-1 and rat Sertoli cells. However, MSC-1 cells lack some of the immune privilege properties associated
with primary Sertoli cells, including survival in animals with a fully functional immune system. Therefore, it has to be kept in
mind that cell lines do not behave identically with primary cells and should not be used to replace primary cells. In order to
strengthen the findings, key control experiments using primary cells should always be performed.
Immortal cell lines are often used in
research in place of primary cells. They
offer several advantages, such as they are
cost effective, easy to use, provide an
unlimited supply of material and bypass
ethical concerns associated with the use of
animal and human tissue. Cell lines also
provide a pure population of cells, which is
valuable since it provides a consistent
sample and reproducible results. Cell lines
have revolutionized scientific research and
are being used in vaccine production,
testing drug metabolism and cytotoxicity,
antibody production, study of gene func-
tion, generation of artificial tissues (e.g.,
artificial skin) and synthesis of biological
compounds e.g., therapeutic proteins.
1-3
Cell line popularity can be estimated by
the numerous publications using cell lines
and American Type Culture Collection
(ATCC) Cell Biology Collection which
consists of over 3,600 cell lines from over
150 different species. However, despite
being a powerful tool, one must be careful
when using cell lines in place of primary
cells. Cell lines should display and main-
tain functional features as close to primary
cells as possible. This may particularly be
difficult to determine as often the func-
tions of the primary cells are not entirely
understood. Since cell lines are genetically
manipulated this may alter their pheno-
type, native functions and their respon-
siveness to stimuli. Serial passage of cell
lines can further cause genotypic and
phenotypic variation over an extended
period of time and genetic drift can also
cause heterogeneity in cultures at a single
point in time. Therefore, cell lines may not
adequately represent primary cells and may
provide different results. The other major
problems associated with cell lines are
contamination with other cell lines and
mycoplasma. The bitter truth of cross-
contamination of cell lines either inter
or intraspecies was exposed by Walter
Nelson-Rees in the early 1970s. He
showed that at that time point the major-
ity of cell lines being used worldwide and
distributed by cell banks were contami-
nated with HeLa cells.
4 This still remains a
problem even after 40 y.
5,6 When con-
tamination of a cell line occurs whereby
a very rapidly proliferating cell line is
introduced, it only takes a few passages
until the culture is entirely taken over by
the contaminating cell line. HeLa cell
contamination is well known to cause
such problems. Additionally, mycoplasma
contamination can persist undetected in
cell cultures for a long period of time and
cause extensive alterations in gene expres-
sion and cell behavior. Based on sub-
missions to cell banks, 15–35% of cell
lines were estimated to be contaminated
with mycoplasma.
7,8 Therefore, great care
should be taken when using cell lines and
experiments where key findings are con-
firmed in primary cultures should always
be included.
Herein we share our experience using
an immortalized mouse Sertoli cell line
(MSC-1), that was developed in 1992 by
Peschon et al.
9 This cell line was isolated
from transgenic mice containing Sertoli
cells transformed by the small and large
T-antigens of the SV40 virus, which were
targeted to Sertoli cells using the pro-
moter for Mullerian inhibiting substance.
MSC-1 cells were similar to primary
Sertoli cells morphologically and expressed
many of the same genes as primary Sertoli
cells.
9,10 Although, follicle-stimulating
hormone receptor (FSHr) and Mullerian
inhibiting substance were not detected in
MSC-1 cells.
9,10
Previously, MSC-1 cells were used to
study the function and regulation of
retinoic acid receptor a (RARa). In these
studies, retinoic acid, activation of protein
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kinase C (PKC) and mitogen activated
protein kinase (MAPK) were shown to
increase the nuclear localization and trans-
criptional activity of RARa.
11 Addition-
ally, peroxisome proliferators inhibited the
retinoic acid-induced nuclear localization
and transcriptional activity of RARa, while
increasing the nuclear localization and
transcriptional activity of peroxisome pro-
liferator-activated receptor a (PPARa)i n
MSC-1 cells.
12 Importantly, the results
were confirmed in primary Sertoli cells
isolated from 20-d old rats,
11,12 which
verified that RARa nuclear localization
and transcription were regulated by reti-
noic acid, PKC, MAPK and peroxisome
proliferators. This demonstrates that
RARa regulation and function is similar
in MSC-1 and primary Sertoli cells and
that MSC-1 cells can be used as a model
to study RARa regulation in primary
Sertoli cells.
However, not all results using the
MSC-1 cell line are consistent with results
from primary Sertoli cells as illustrated by
studies on immune privilege.
13,14 Immune-
privileged sites are anatomical sites where
foreign tissues survive for extended periods
of time because immune surveillance is
reduced, and thus foreign antigens can be
tolerated without evoking a detrimental
immune response. The testis is an
immune-privileged site that results in
protection of the auto-immunogenic germ
cells (when germ cells are removed from
the testis and injected at a different site in
the same animal, the cells are rejected).
15
Sertoli cells play an important role in
creating this immune-privileged environ-
ment by expressing several immuno-
regulatory factors.
16-19 Moreover, isolated
Sertoli cells survive and prolong the survi-
val of co-transplanted cells when trans-
planted as allografts
20,21 or xenografts.
22
Similarly, Sertoli cells grafted alone across
species survive longer than other cell
types.
23,24
To compare the immunoprotective
properties of MSC-1 cells with primary
Sertoli cells, MSC-1 cells were co-
transplanted with BALB/c pancreatic
islets as allografts into diabetic C3H mice.
The islets were rejected in 32.8 ± 8.4 d,
which was not significantly different
from control mice that received allogeneic
islets alone (26.9 ± 2.1 d). In contrast,
co-transplantation of BALB/c primary
Sertoli cells with BALB/c islets as allo-
grafts into diabetic C3H mice significantly
prolonged islet graft survival (. 61.1 ±
6.9 d), with 59% of the Sertoli cell/islet
co-grafts surviving throughout the study
period.
14 In addition, 100% graft survival
was observed when primary Sertoli cells
were transplanted alone as allografts into
naïve BALB/c mice for 20 d.
13 In contrast,
MSC-1 cells were unable to protect co-
grafted cells in diabetic animals and were
themselves rejected when transplanted
into naïve mice with a fully functional
immune system.
13,14 This emphasizes the
importance of being cautious before
assuming results obtained from cell lines
are the same as those obtained using
primary cells.
Interestingly, MSC-1 cells did survive in
66% of the recipient diabetic mice even
though the islet grafts were rejected.
14
This is most likely due to the suppressed
immune system associated with diabetes
and suggests MSC-1 cells express some
immunoprotective factors but lack or have
lower expression of the key factors needed
for immune protection of co-grafted cells
and for fully functional immune privilege.
Thus, MSC-1 cells may not mimic the
survival and immune privilege properties
of primary Sertoli cells but are useful as
a control cell line to identify the key
mechanisms or factors important for
primary Sertoli cell immune privilege. To
identify genes and immune-related func-
tional pathways that are differentially
regulated in these cells gene expression
profiles of primary mouse Sertoli cells
and MSC-1 cells were compared by
microarray and ontological analyses.
13 We
found that 2,369 genes were expressed
with a ± 4-fold or higher level in primary
Sertoli cells than in MSC-1 cells. Genes
involved in immune functions were
identified and differentially expressed.
13
While the Sertoli cells and MSC-1 cells
express many of the same genes, they
were expressed at different levels which
appear to result in different immune
regulatory functions. This confirms that
the MSC-1 cell line is substantially dif-
ferent from primary mouse Sertoli cells
and reiterates the importance of being
cautious when making conclusions based
on the results from cell lines.
As mentioned earlier, FSHr was not
detected in MSC-1 cells.
10 FSHr is acti-
vated by follicle-stimulating hormone
(FSH) and is important for Sertoli cell
proliferation, macromolecular synthesis,
morphological structure, and ultimately
the spermatogenic capability.
25 However,
the role of FSH in creation of an immune
privileged environment is not clear. In
one study there was an increase in testi-
cular graft size/survival after transplanting
to oophorectomized rodents that corre-
lated with FSH and luteinizing hormone
(LH) levels.
26 Additionally, Selawry et al.,
demonstrated that media collected from
rat Sertoli cells cultured at 37°C for 24 h
supplemented with FSH significantly
inhibited the ConA stimulated prolifera-
tion of spleen lymphocytes, suggesting
FSH may be important for Sertoli cells
immune protection.
27 In contrast, the
same group also demonstrated that pro-
tection of cellular grafts within the testis
was not dependent on FSH or LH as
treatment of rats with a gonadotropin-
releasing hormone (GnRH) analog or
hypophysectomy had no effect on the
survival of transplanted intratesticular
islet allografts.
28
Since FSHr is known to be important
for the function of primary Sertoli cells
and MSC-1 cells lack FSHr, the survival
of MSC-1 cells stably transfected with
FSHr (MSC-1FSHr) was examined after
allotransplantation. MSC-1FSHr cells
were shown previously to express func-
tional FSHr as demonstrated by northern
blot analysis and increased c-fos mRNA
after FSH treatment.
29 Prior to trans-
plantation, the expression of FSHr was
confirmed by RT-PCR and as expected,
FSHr mRNA was not detected in MSC-1
cells (Fig.1A, lane 3) while MSC-1FSHr
cells expressed FSHr mRNA (Fig.1A,
Lane 2). Four million MSC-1 or MSC-
1FSHr cells were cultured as aggregates
(Fig.1C and D) and transplanted into
naïve BALB/c mice as allografts. Graft-
bearing kidneys were removed 20 d post-
transplantation and examined for cell
survival by immunohistochemistry for
SV-40 large T antigen and RT-PCR for
FSHr. Consistent with the previous
survival data in naïve mice, MSC-1 cell
grafts were rejected (0/6) by 20 d
post-transplantation (Fig.1F). Similarly,
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Figure1. FSHr mRNA expression and survival of MSC-1 and MSC-1FSHr cells as allografts. MSC-1 cells stably transfected with rat FSHr cDNA were
obtained from Dr. Griswold (Washington State University, Pullman, WA).
29 MSC-1FSHr cells were maintained and cultured essentially the same as MSC-1
cells with the exception of the addition of 250 mg/ml G418 (Invitrogen, Carlsbad, CA). A and B) RT-PCR was performed for FSHr (A), Lanes 2 and 3;
Primers-For 5’CCA TTG TGT CCT CAT CAA GC, Rev 5’CAT GGA AGT TGT GGG TAG CG) or cyclophilin (B), Lanes 2 and 3; Primers-For 5’CCC ACC GTG TTC
TTC GAC, Rev 5’ATC TTC TTG CTG GTC TTG CC) with RNA isolated from MSC-1FSHr (A and B, Lane 2) or MSC-1 cells (A and B, Lane 3). Lane 1 (A and B) is
1 kb Plus DNA Ladder (Invitrogen). (C and D) MSC-1 (D) or MSC-1FSHr (C) cells were cultured as aggregated for 48 h. Aggregates were fixed, dispersed
in agar, embedded in paraffin, sectioned and immunostained for large T antigen (brown color) and hematoxylin (blue color). (E-H) Four million of
these aggregated cells were transplanted under the kidney capsule of naïve (E and F) and diabetic (G and H) BALB/c mice. The grafts were collected at
day 20 post-transplantation, and tissue sections were immunostained for MSC-1 cell marker, large T antigen (brown color, E-H). All sections were
counterstained with hematoxylin (blue color). A dotted line separates the kidney from the graft. K, kidney; Arrow, large T antigen positive cells. Care and
maintenance of animals described in (E-H) was performed in accordance with the Institute for Laboratory Animal Research Care and Use of Laboratory
Animals, and Texas Tech University Institutional Animal Care and Use Committee-approved protocols.
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MSC-1FSHr grafts were also rejected in
naïve BALB/c animals and no large T
antigen positive MSC-1FSHr cells or
FSHr mRNA were detected at 20 d post-
transplantation (0/7) (Fig.1E, data not
shown). In contrast, both MSC-1 (2/2)
and MSC-1FSHr (4/4) cells survived in
diabetic mice at 20 d post-transplantation
as shown by large T antigen staining
(Fig.1G–H) and RT-PCR for FSHr
mRNA (MSC-1FSHr only; data not
shown). However, the MSC-1FSHr grafts
were slightly smaller than the MSC-1 cell
grafts (Fig.1, compare G and H). This
indicates that the addition of functional
FSHr to MSC-1 cells does not compensate
for the loss of immune privilege.
Immune privilege involves a complex
interplay between immunoregulatory
factors, the transplant environment and
the host’s immune system. Thus, addition
of just one factor e.g., FSHr to a cell line
does not make it immune-privileged.
Other studies have identified several
potential pathways or factors that may
contribute to Sertoli cell immune pri-
vilege.
13 For example, Sertoli cells express
or secrete complement inhibitors, apo-
ptosis inhibitors and factors that modu-
late the immune response. Thus, it seems
likely that a combination of several factors
is required to make Sertoli cells immune-
privileged. Overall, the MSC-1 cell line
may serve as a good comparison cell line
to study key factors/mechanisms required
for primary Sertoli cell immune privilege
but they should not be used in place of
primary Sertoli cells to study survival
mechanisms.
A different MSC-1FSHr cell line was
created by Eskola et al.
30 In this cell line,
intact FSHR signaling and function,
similar to Sertoli cells was verified by
cAMP response to FSH and PKC.
Antiproliferative effects of FSH on MSC-
1FSHr further demonstrated that these
cells resemble adult Sertoli cells and thus
can be used a model to study post-
transcriptional regulation of FSHR and
its signal transduction.
30 However, regula-
tion of inhibin-a expression in response
to FSH was different from primary Sertoli
cells. In a separate study, the basal and
cAMP regulated expression of PKA sub-
units was compared in MSC-1 cells to rat
Sertoli cells.
31 This study demonstrates
that the RIIβ mRNA basal levels, magni-
tude of induction of RIIβ mRNA by
cAMP, half-life after cAMP removal and
mRNA induction independent of protein
synthesis is different from primary rat
Sertoli cells.
31 These results further
demonstrate that even though a Sertoli
cell line retains major characteristics of
primary Sertoli cells; they do not com-
pletely replicate primary Sertoli cells.
In conclusion, cell lines are a powerful
tool and offer several advantages over
primary cells. However, it must be
understood that cell lines do not comple-
tely mimic primary cells. Therefore, great
caution should be taken when designing
experiments to assure that the conclusions
drawn from cell line are sound. Key
experiments should also be replicated in
primary cells.
Finally, it should be recognized that a
weakness of in vitro cell cultures, both
primary cells and cell lines, is that they are
being studied in the absence of their local
environment that often includes interac-
tions with other cell types that may be
critical to the hypothesis being tested.
Sertoli cells are well known to interact
with other cell types in the local environ-
ment and therefore these cells are parti-
cularly vulnerable to deficiencies of the
isolated or enriched culture environment.
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